Search Results - "Wu, Yue‐E"
-
1
Machine Learning: A New Approach for Dose Individualization
Published in Clinical pharmacology and therapeutics (01-04-2024)“…The application of machine learning (ML) has shown promising results in precision medicine due to its exceptional performance in dealing with complex…”
Get full text
Journal Article -
2
Prognostic value of infarct-related-lead Tpeak–Tend/QT ratio in patients with ST-segment elevation myocardial infarction
Published in Heart and vessels (01-04-2022)“…Tpeak–Tend/QT ratio (Tp–e/QT) in patients with ST-segment elevation myocardial infarction (STEMI) is reportedly associated with major adverse cardiac events…”
Get full text
Journal Article -
3
Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia
Published in British journal of clinical pharmacology (01-05-2024)“…Aims Levofloxacin is a quinolone antibiotic with a broad antibacterial spectrum. It is frequently used in elderly patients with pneumonia. The pharmacokinetic…”
Get full text
Journal Article -
4
Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates
Published in Clinical pharmacokinetics (01-08-2023)“…Background and Objective High variability in vancomycin exposure in neonates requires advanced individualized dosing regimens. Achieving steady-state trough…”
Get full text
Journal Article -
5
Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
Published in Journal of antimicrobial chemotherapy (28-07-2022)“…Abstract Objectives Mezlocillin is used in the treatment of neonatal infectious diseases. However, due to the absence of population pharmacokinetic studies in…”
Get full text
Journal Article -
6
Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China
Published in British journal of clinical pharmacology (01-03-2021)“…Aims The aim of the study was to evaluate the suitability of the current caffeine dosing regimen for the Chinese population using modelling and simulation…”
Get full text
Journal Article -
7
Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction
Published in Clinical pharmacokinetics (01-11-2021)“…Background Population pharmacokinetic evaluations have been widely used in neonatal pharmacokinetic studies, while machine learning has become a popular…”
Get full text
Journal Article -
8
Clinical utility of a model‐based amoxicillin dosage regimen in neonates with early‐onset sepsis
Published in British journal of clinical pharmacology (01-11-2022)“…Early‐onset sepsis (EOS) is one of the most significant causes of morbidity and mortality in neonates. Currently, amoxicillin is empirically used to treat…”
Get full text
Journal Article -
9
Epithelial lining fluid concentrations of ceftriaxone in children with community‐acquired pneumonia
Published in British journal of clinical pharmacology (01-04-2023)“…Ceftriaxone is widely used in children with community‐acquired pneumonia. Currently, there are no available data regarding epithelial lining fluid (ELF)…”
Get full text
Journal Article -
10
Relationship Between Linezolid Exposure and the Typical Clinical Laboratory Safety and Bacterial Clearance in Chinese Pediatric Patients
Published in Frontiers in pharmacology (01-08-2022)“…Objectives: There have been limited studies concerning the safety and efficacy of linezolid (LZD) in children. This study aimed to evaluate the association…”
Get full text
Journal Article -
11
Editorial: Model-Based Evaluation of Antimicrobial Agents in Children
Published in Frontiers in pharmacology (16-08-2021)Get full text
Journal Article -
12
Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
Published in Frontiers in pharmacology (07-09-2022)“…Objective: The perspective of real-world study is especially relevant to newborns, enabling dosage regimen optimization and regulatory approval of medications…”
Get full text
Journal Article -
13
Clinical utiliy of a model‐based piperacillin dose in neonates with early‐onset sepsis
Published in British journal of clinical pharmacology (01-03-2022)“…Aims Early‐onset sepsis (EOS) is a common disease in neonates with a high morbidity and mortality rate. Piperacillin/tazobactam has been used extensively and…”
Get full text
Journal Article -
14
Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants
Published in Journal of clinical pharmacology (01-04-2021)“…Amoxicillin is used to treat various bacterial infections (eg, pneumonia, sepsis, meningitis) in infants. Despite its frequent use, there is a lack of…”
Get full text
Journal Article -
15
Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis
Published in European journal of pharmaceutical sciences (01-08-2021)“…Ceftazidime is a third-generation cephalosporin with high activity against many pathogens. But the ambiguity and diversity of the dosing regimens in neonates…”
Get full text
Journal Article -
16
Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
Published in Frontiers in pharmacology (18-11-2022)“…The decision of vancomycin dosage for central nervous system (CNS) infections is still a challenge because its bactericidal nature in cerebrospinal fluid (CSF)…”
Get full text
Journal Article -
17
Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
Published in Frontiers in pharmacology (04-02-2020)“…Cefepime is used to treat severe infections in neonates. Pharmacokinetic data have only been evaluated among preterm neonates and population pharmacokinetic…”
Get full text
Journal Article -
18
Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
Published in Frontiers in pharmacology (11-09-2020)“…Carbapenem-resistant enterobacteriaceae (CRE) bloodstream infections have been rapidly spreading worldwide with a high mortality and pose a challenge to…”
Get full text
Journal Article -
19
Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial
Published in Frontiers in pharmacology (17-11-2022)“…Background: Pneumonia, caused by infection or other factors, seriously endangers the health of children. Meropenem is an effective broad-spectrum antibiotic…”
Get full text
Journal Article -
20
Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug
Published in Frontiers in pharmacology (06-07-2021)“…Objective: The elucidation of CYP2D6 developmental pharmacogenetics in children has improved, however, these findings have been largely limited to studies of…”
Get full text
Journal Article